Catalyst Biosciences, Inc. ( CBIO) - Stock Earnings
Stock symbol CBIO is outdated, potentially delisted? Maybe it is available on other exchange?
CBIO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q3 | -4.9 million USD | 0 USD |
| 2023Q1 | 260000 USD | — USD |
| 2023Q2 | -2.5 million USD | — USD |
CBIO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2019 | -55.2 million USD | 0 USD |
| 2020 | -56.2 million USD | 20.9 million USD |
| 2021 | -87.9 million USD | 7.3 million USD |
CBIO
Price: $0.51
52 week price:
Dividend Yield: 792.92%
Earnings Per Share: -0.03 USD
P/E Ratio: 1.67
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Ebitda: -5.8 millionMarket Capitalization: 19.4 million